KRAS and breast cancer: SK1 KD in breast cancer cell lines downregulated Myc, G2/M cell cycle and E2F pathways (Table 1) and upregulated KRAS, IL2/signal transducer and activator of transcription (STAT)5 and tumor necrosis factor (TNF)/NFκB pathways.